FOLH1 and neoplasm: In the present study, we conducted extensive state-of-the-art 3D SPECT/CT dosimetry which revealed low tumor-absorbed doses, possibly explaining the lack of efficacy of [177Lu]Lu-PSMA-I&T in SGC patients.